Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of reactive arthritis.

J Sieper1

  • 1Department of Internal Medicine I, Rheumatology, University Hospital Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. hjsieper@zedat.fu-berlin.de

Current Rheumatology Reports
|September 21, 2001
PubMed
Summary

Bacteria persist in patients with reactive arthritis (ReA), potentially due to an inhibited T-helper 1 cell response. Understanding the role of HLA-B27 in antigen presentation may lead to new immunomodulatory therapies for chronic ReA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[History of the treatment of axial spondylarthritis with biologics-Part 1].

Zeitschrift fur Rheumatologie·2022
Same author

[Development of quality standards for patients with axial spondyloarthritis for use in Germany].

Zeitschrift fur Rheumatologie·2021
Same author

[Is it possible to delegate medical services to qualified nurses specialized in rheumatology when evaluating patients with suspicion of ankylosing spondylitis?-Results of the PredAS study].

Zeitschrift fur Rheumatologie·2020
Same author

[Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Zeitschrift fur Rheumatologie·2019
Same author

[Pathogenesis of spondylarthritis : Relevance for treatment].

Zeitschrift fur Rheumatologie·2019
Same author

[Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a routine data analysis].

Zeitschrift fur Rheumatologie·2019

Area of Science:

  • Immunology
  • Microbiology
  • Rheumatology

Background:

  • Reactive arthritis (ReA) is characterized by persistent bacterial presence in patients.
  • Specific bacteria like Chlamydia, Salmonella, and Yersinia reside in different tissues, including joints, gut mucosa, and lymph nodes.
  • T-helper 1 (Th1) cells and their cytokines (IFN-gamma, TNF-alpha) are vital for bacterial clearance, but their response is often inhibited in ReA.

Purpose of the Study:

  • To investigate the mechanisms of bacterial persistence in reactive arthritis.
  • To explore the role of T-helper 1 cell response inhibition in ReA pathogenesis.
  • To understand the association between HLA-B27 and the development of chronic spondyloarthropathy features in ReA patients.

Main Methods:

  • The study reviews existing evidence on bacterial persistence and immune responses in ReA.
  • It discusses the role of Th1 cells and cytokines in bacterial elimination.
  • Hypotheses regarding HLA-B27's interaction with bacterial or self-antigens presented to CD8(+) T-cells are examined.

Main Results:

  • Bacterial persistence in vivo is evident in ReA patients, with different bacteria localizing to distinct sites.
  • An inhibited Th1 response is observed in ReA, likely contributing to bacterial persistence.
  • HLA-B27 is crucial for chronic spondyloarthropathy development and may present unknown antigens to CD8(+) T-cells.

Conclusions:

  • Bacterial persistence and impaired Th1 responses are key features of reactive arthritis.
  • The interaction between bacteria, HLA-B27, and T-cells, particularly CD8(+) T-cells, is critical in ReA immunopathology.
  • Future treatments for ReA may involve immunomodulatory therapies, potentially combined with antibiotics, targeting the underlying pathogenesis.

Related Experiment Videos